Literature DB >> 6204100

Muscle biopsy studies in chronically uremic patients: evidence for malnutrition.

G Guarnieri, G Toigo, R Situlin, L Faccini, U Coli, S Landini, G Bazzato, F Dardi, L Campanacci.   

Abstract

Evidence for muscle protein wasting and abnormal muscle metabolism is common in uremia. Muscle DNA content is considered a reliable reference standard in normal and undernourished adults. Muscle RNA content rapidly changes during starvation and refeeding. The ratio of noncollagen alkali-soluble proteins (ASP) to DNA is considered to be an estimate of the cytoplasmic volume of a single cell, and the RNA: DNA ratio is an index of the ribosomal capacity for protein synthesis. Muscle DNA, RNA, ASP, water, and fat content were determined in muscle biopsy specimens from chronically uremic patients receiving conservative treatment (CT), maintenance hemodialysis (two centers), or CAPD. Nutrient intake was low and the anthropometric indices were decreased in all groups of patients, except in the hemodialysis patients from one center. Serum proteins and muscle ASP: DNA and RNA: DNA ratios were decreased. The nutritional status was reassessed in some malnourished CAPD patients after about one year of careful nutritional advice and was unchanged. These results suggest that chronically uremic patients on CT are often malnourished, primarily because of an inadequate protein and/or energy intake. Muscle nucleic acid and protein content are useful tools for nutritional assessment at a cellular level in humans with chronic renal failure and can be used to monitor the response to nutritional therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6204100

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  8 in total

1.  Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients.

Authors:  G Garibotto; A Barreca; R Russo; A Sofia; P Araghi; A Cesarone; M Malaspina; F Fiorini; F Minuto; A Tizianello
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

2.  Conchotome and needle percutaneous biopsy of skeletal muscle.

Authors:  P Dietrichson; J Coakley; P E Smith; R D Griffiths; T R Helliwell; R H Edwards
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

Review 3.  Central and peripheral adaptations to physical training in patients with end-stage renal disease.

Authors:  E J Kouidi
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

4.  Activation of caspase-3 in the skeletal muscle during haemodialysis.

Authors:  Michel A Boivin; Shadi I Battah; Elizabeth A Dominic; Kamyar Kalantar-Zadeh; Arny Ferrando; Antonios H Tzamaloukas; Rama Dwivedi; Thomas A Ma; Pope Moseley; Dominic S C Raj
Journal:  Eur J Clin Invest       Date:  2010-08-19       Impact factor: 4.686

Review 5.  Neurological complications of chronic kidney disease.

Authors:  Arun V Krishnan; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2009-09-01       Impact factor: 42.937

6.  Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect.

Authors:  H Ding; X L Gao; R Hirschberg; J V Vadgama; J D Kopple
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

7.  Impact of long-term hemodialysis on nutritional status in patients with end-stage renal failure.

Authors:  P Kaufmann; K H Smolle; J H Horina; R Zach; G J Krejs
Journal:  Clin Investig       Date:  1994-10

8.  Yi-Qi-Jian-Pi-Xiao-Yu-Xie-Zhuo Formula Improves Muscle Atrophy via Modulating the IGF-1/PI3K/Akt Signaling Pathway in 5/6 Nephrectomized Rats.

Authors:  Hong Xia; Bingbing Zhang; Dan Yang; Chengyue Zhu; Jiudan Zhang; Hongbo Chen; Hongzhen Ma; Shouci Hu; Chao Xu; Chengqian Shi; Keda Lu; Peipei Zhang
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.